Study Information

Purpose of Study

Primarily to test the efficacy of MET-2, a gut repopulating biological product, on depression and anxiety symptoms, as well as the safety and tolerability of the product.

Lab

Milev Laboratory.

Who is Conducting the Study?

Arthi Chinna Meyyappan

Location

Providence Care Hospital. Kingston, ON.

Compensation Info

Yes, $50 for every in-hospital visit (for a total of 5 visits).


Inclusion/Exclusion Criteria

Inclusion:
  1. Between the ages 18-65
  2. Depressed or anxious
  3. Not currently taking any antidepressants
Exclusion:
  1. You are currently not taking any antidepressent medication

Times Available

Any time during the week Please contact Arthi via the contact researcher button below and we can coordinate times

Contact Researcher Back to Browse



Share this study with someone you know!